Clinical Trial Update: Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200) [Phase 2]

View source ↗

Summary

Phase 2 trial update for avelumab in Merkel cell carcinoma (JAVELIN Merkel 200) has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Carcinoma, Merkel Cell | Phase 2 | Status: COMPLETED | Results posted: 2020-07-22